RNA Therapeutic for RP11 Eye Disease

PYC Therapeutics

This video provides an overview of retinitis pigmentosa type 11 (RP11) and the mechanism of action (MoA) of PYC’s mRNA therapeutic candidate, VP-001.

Previous
Previous

RNA Therapeutic for Phelan-McDermid Syndrome / MoA / PYC Therapeutics

Next
Next

Bowel Cleansing / Undisclosed